Bank of America
HCWB icon

Bank of America’s HCW Biologics HCWB Stock Holding History

Bank of America’s Portfolio HCWB Stock Details HCWB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2
Closed -$11 – 6227
2025
Q4 		$11 Hold
2
– – ﹤0.01% 7193
2025
Q3 		$37 Hold
2
– – ﹤0.01% 8075
2025
Q2 		$40 Buy
2
+1
+100% +$44 ﹤0.01% 8144
2025
Q1 		$59 Hold
1
– – ﹤0.01% 7943
2024
Q4 		$65 Hold
1
– – ﹤0.01% 7825
2024
Q3 		$183 Hold
1
– – ﹤0.01% 7590
2024
Q2 		$101 Sell
1
-1
-50% -$295 ﹤0.01% 7697
2024
Q1 		$710 Buy
+2
New +$639 ﹤0.01% 7248
2023
Q4 		– Hold
0
– – – 7736
2023
Q1 		– Hold
0
– -$80 – 7994
2022
Q4 		– Hold
0
– – – 7709
2022
Q1 		– Hold
0
– – – 8451
2021
Q4 		– Hold
0
– – – 8380

Other funds holding HCWB

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America's HCWB Position: Q1 2026 in Review

Bank of America sold out of HCW Biologics (HCWB) in Q1 2026, closing a stake of 2 shares — an estimated $11 sold.

Bank of America first reported a position in HCWB in Q1 2024 and held it in 8 quarters. The position peaked at $710 in Q1 2024. 13 funds tracked by Wall St. Rank hold HCWB as of Q1 2026.

  • Bank of America reported no remaining HCW Biologics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 2 HCW Biologics shares in Q1 2026, an estimated $11.
  • Bank of America first reported a position in HCW Biologics in Q1 2024 and held it in 8 quarters.
  • Bank of America's HCW Biologics position peaked at $710 in Q1 2024.
  • 13 funds tracked by Wall St. Rank held HCW Biologics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.